JPMorgan Chase & Co. lowered shares of Basf (OTCMKTS:BASFY – Free Report) from a neutral rating to an underweight rating in a report issued on Thursday morning, Marketbeat Ratings reports.
Several other equities analysts have also recently commented on the stock. Berenberg Bank cut shares of Basf from a “buy” rating to a “hold” rating in a research report on Tuesday, February 18th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Basf in a report on Friday, March 7th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold”.
Read Our Latest Research Report on Basf
Basf Price Performance
Basf (OTCMKTS:BASFY – Get Free Report) last released its earnings results on Friday, February 28th. The basic materials company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.05. The company had revenue of $16.92 billion during the quarter, compared to the consensus estimate of $15.72 billion. Basf had a return on equity of 6.63% and a net margin of 0.78%. As a group, analysts forecast that Basf will post 0.83 EPS for the current year.
Basf Company Profile
BASF SE operates as a chemical company worldwide. It operates through six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. The Chemicals segment provides petrochemicals and intermediates. The Materials segment offers advanced materials and their precursors for applications and systems comprising isocyanates, polyamides, and inorganic basic products, as well as specialties for plastics and plastics processing industries.
See Also
- Five stocks we like better than Basf
- With Risk Tolerance, One Size Does Not Fit All
- MarketBeat Week in Review – 03/24 – 03/28
- What is the S&P/TSX Index?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Profitably Trade Stocks at 52-Week Highs
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Basf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basf and related companies with MarketBeat.com's FREE daily email newsletter.